SAN DIEGO, Jan. 11, 2010 (GLOBE NEWSWIRE) -- OccuLogix, Inc., dba TearLab Corporation (“TearLab”) (Nasdaq:TEAR) (TSX:TLB) today announced the sale of 1,886,291 shares of its common stock for an aggregate of approximately $1,700,000. This is the maximum currently allowable by the rules of the NASDAQ Capital Market without stockholder approval.
